Carrie Nagorka, Senior Editor

Leading clinicians discuss sun protection best practices based on weather, climate, and travel needs.

Leading clinicians discuss sun protection and special issues in photosensitivity.

Leading clinicians debunk 5 of the most common sunscreen myths.

Leading clinicians discuss sun protection best practices and recommendations for the upcoming summer months.

Results of a new study indicate that baricitinib offers a potential therapeutic option with a favorable benefit-risk profile for pediatric patients with moderate-to-severe AD.

The results of a new study reveal that the the antibody works by activating the immune response to fight cancer and slows melanoma growth in mice.

The risk remained significantly increased for both sexes as well ,whether or not the patient had depression, substance use disorder, or alcohol use disorder.

Results of the phase 3 ECZTRA 6 trial found that the efficacy of the drug was maintained by more than 50% of patients at 52 weeks.

A new study revealed that psoriasis patient adherence is influenced by certain characteristics of topical medications.

Researchers also investigated how electric stimulation could be used to speed up wound healing in connection with diabetes, which affects wound healing due to impaired circulation and nerve damage.

The task force defined screening as a visual skin exam by a primary care clinician for this recommendation.

The findings suggest a need to conduct cancer screening by a detailed history and comprehensive clinical examination in patients with PsA.

The combination of punica granatum, citrus sinesis, f. cistanche, and centella asiatica revealed improved skin moisturization, radiance, and elasticity in a new study.

The Minghui Pharmaceutical study met both primary and all key secondary endpoints.

Oral vitamin D supplementation does not appear to have an effect on disease severity for those with low 25-hydroxyvitamin D (25[OH]D) levels.

This will be the first clinical study in dermatology to assess patients’ wellbeing as a primary endpoint.

The study was the first to examine the fruit's properties as a wound-healing agent and skin protectant.

ADX‑629 also is being evaluated in Phase 2 clinical trials for the treatment of chronic cough, idiopathic nephrotic syndrome, and Sjögren-Larsson Syndrome.

The study suggests that treatments for allergic reactions could help decrease the risk of having joint problems.

April has been designated Rosacea Awareness Month by The National Rosacea Society (NRS) in an effort to educate the public on the impact of this chronic and widespread facial disorder.

The Dermatology Times® team is spotlighting rosacea treatments during this Rosacea Awareness Month.

The 2 votes came at the end of the second day of a joint meeting of the FDA's Drug Safety and Risk Management Advisory Committee and Dermatologic and Ophthalmic Drugs Advisory Committee.

Jodi Westfall, NP, explains how she improves common skin conditions traditionally and from a metabolic perspective.

The robotic device was previously cleared to treat patients' full abdomen and flanks.

There are currently no FDA approved therapies in this treatment setting.

Although the ingredient is widely used in skincare, the American Contact Dermatitis Society (ACDS) wants clinicians to take special considerations when patch testing for lanolin contact allergy.

The study also found lasting benefits of the supplement for bone density up to age 4.

The selective and reversible Janus kinase inhibitor is being studied in several immune-mediated inflammatory diseases.

Results from the phase 3 DERMIS-1 and DERMIS-2 trials were presented at the 2023 American Academy of Dermatology Annual Meeting.

A pair of phase 3 trials met all primary and secondary endpoints after 48 weeks.